EUVIMEDEUVIMED entdecken
Validierungsstudie

Hepatobiliary phase radiomics for identifying subclinical liver dysfunction in compensated chronic liver disease: development and external validation

Fatih Işık, Serdar Sipahioğlu, Muhammed Emre Işıktaş, Muhammed Halid Yener, Mehmet Alperen Tezcan, Nurullah Dag, Hakan Dursun, Fatih Alper

Abdominal Radiology · 2026

DOI: 10.1007/s00261-026-05537-7 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Abdominal Radiology, 2026. Verfasst von Fatih Işık und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Erzurum Regional Training and Research Hospital, Erzurum, Turkey. drfatih.isik@icloud.com. Hauptthemen laut MEDLINE: Radiomics, Magnetic Resonance Imaging, Liver Diseases. Die Arbeit nennt 37 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: To develop and externally validate a radiomics model derived from gadoxetic acid-enhanced hepatobiliary phase (HBP) MRI for detecting subclinical liver dysfunction in patients with compensated chronic liver disease (CLD). METHODS: In this retrospective study, patients were included based on Child-Pugh Class A status and absence of clinical decompensation. Subclinical liver dysfunction was defined using a composite reference standard integrating ALBI score ( > - 2.60), MELD-Na ≥ 10, and FIB-4 ≥ 2.67. Whole-liver radiomic features were extracted from HBP images. Feature selection and model development were performed using Boruta and class-weighted logistic regression within a nested cross-validation framework. RESULTS: A total of 138 individuals (90 patients with subclinical liver dysfunction and 48 controls) were analyzed. Six radiomic features were selected for model development. In the internal test cohort (n = 21), the model achieved a ROC-AUC of 0.86 [95% CI: 0.66-1.00] with an accuracy of 0.81 [95% CI: 0.62-0.95]. In the external validation cohort (n = 26), the model achieved a ROC-AUC of 0.89 [95% CI: 0.73-0.99] and an accuracy of 0.77 [95% CI: 0.58-0.92] using a fixed decision threshold. Both first-order and texture-based features were represented among the selected predictors. CONCLUSION: HBP-derived radiomics demonstrates potential as a noninvasive biomarker for identifying subclinical liver dysfunction in compensated CLD patients. While the results are promising, the relatively small validation cohorts warrant cautious interpretation, and further validation in larger multicenter populations is required to confirm robustness and generalizability.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RadiomicsMagnetic Resonance ImagingLiver DiseasesHumansFemaleRetrospective StudiesContrast MediaMaleGadolinium DTPAChronic DiseaseMiddle AgedAgedReproducibility of Results

Stichwörter der Autor:innen

Computer-assistedContrast mediaImage processingLiverLiver diseasesLiver function testsMagnetic resonance imaging

Substanzen

Contrast Mediagadolinium ethoxybenzyl DTPAGadolinium DTPA

Autor:innen und Institutionen

  • Department of Radiology, Erzurum Regional Training and Research Hospital, Erzurum, Turkey. drfatih.isik@icloud.com.
  • Department of Radiology, Ankara Dışkapı Yıldırım Beyazıt Training and Research Hospital, Ankara, Turkey.
  • Department of Radiology, Faculty of Medicine, Atatürk University, Erzurum, Turkey.
  • Department of Radiology, Faculty of Medicine, Balikesir University, Balikesir, Turkey.
  • Department of Radiology, Faculty of Medicine, Inonu University, Malatya, Turkey.
  • Department of Gastroenterology, Faculty of Medicine, Atatürk University, Erzurum, Turkey.

Zitieren

APA

Işık, F., Sipahioğlu, S., Işıktaş, M. E., Yener, M. H., Tezcan, M. A., Dag, N., Dursun, H., & Alper, F. (2026). Hepatobiliary phase radiomics for identifying subclinical liver dysfunction in compensated chronic liver disease: development and external validation. Abdominal Radiology. https://doi.org/10.1007/s00261-026-05537-7

Vancouver

Işık F, Sipahioğlu S, Işıktaş ME, Yener MH, Tezcan MA, Dag N, et al. Hepatobiliary phase radiomics for identifying subclinical liver dysfunction in compensated chronic liver disease: development and external validation. Abdominal Radiology. 2026. doi:10.1007/s00261-026-05537-7

BibTeX
@article{Ik2026,
  author = {Işık, Fatih and Sipahioğlu, Serdar and Işıktaş, Muhammed Emre and Yener, Muhammed Halid and Tezcan, Mehmet Alperen and Dag, Nurullah and Dursun, Hakan and Alper, Fatih},
  title = {Hepatobiliary phase radiomics for identifying subclinical liver dysfunction in compensated chronic liver disease: development and external validation},
  journal = {Abdominal Radiology},
  year = {2026},
  doi = {10.1007/s00261-026-05537-7}
}
Kostenlos starten →